Capecitabine in combination with irinotecan (XELIRI), administered as a 2-weekly schedule, as first-line chemotherapy for patients with metastatic colorectal cancer: A phase II study of the Spanish GOTI group

1. Garcia-Alfonso, P.
2. Mũoz-Martin, A.
3. Mendez-Urẽa, M.
4. Quiben-Pereira, R.
5. Gonzalez-Flores, E.
6. Perez-Manga, G.